Jeffrey Hermanson is a partner in the Corporate Practice Group, and a member of the Mergers and Acquisitions Practice Group. He joined the firm in 1987.
Practice
Mr. Hermanson’s practice focuses on mergers and acquisitions, including divisional transactions and acquisitions and dispositions of public and private companies. He also has a background in commercial real estate where he has represented purchasers and sellers of commercial, retail, office and multifamily residential property. In addition, Mr. Hermanson has experience in finance, equipment leasing and project finance.
Recent Highlights
Representation of:
- Prism Pharmaceuticals, Inc. in its sale to Baxter Healthcare Corporation
- Gloucester Pharmaceuticals in its sale to Celgene Corporation
- SkillSoft plc in its acquisition of Thomson Learning's NETg Business
- GloNav Inc. in its sale to NXP Semiconductors
- Parexel in its acquisition of APEX International Clinical Research
- Alnylam Pharmaceuticals in the sale of its German operations to Roche
- GlycoFi Inc. in its sale to Merck & Co., Inc.
- Xanthus Inc. in its sale to Antisoma Research Limited
- Intercontinental Real Estate in its acquisition of Marine Lumber Company
- Nationwide Health Properties in its acquisition of Epoch Senior Living
- Rolls Royce Naval Marine in its acquisition of Seaworthy Systems, Inc.
- Berkshire Mortgage Finance in its acquisition by Deutsche Bank